-- 週四早盤,油價回落,此前有報告美國可能結束與伊朗的停火協議。這場史上最大的供應衝擊對依賴波斯灣石油供應的非洲大陸打擊尤為嚴重,而這些石油目前被封鎖在霍爾木茲海峽後。 6月交割的西德州中質原油(WTI)價格下跌2.44美元,至每桶104.44美元,此前隔夜一度觸及每桶110.93美元;6月交割的布蘭特原油價格下跌4.01美元,至每桶114.02美元,此前隔夜一度觸及1262.34美元,12622年的最高桶。 自2月28日戰爭爆發以來,WTI原油價格已上漲59%。 2月28日,在美國和以色列發動攻擊後,伊朗封鎖了霍爾木茲海峽,該海峽是全球約20%石油供應的關鍵咽喉要道。美國目前封鎖了伊朗港口,伊朗要求在恢復和平談判前解除封鎖,但美國拒絕這樣做,導致伊朗持續遭受史上最嚴重的供應衝擊。 這次短缺對亞洲的影響最為嚴重,亞洲購買了波斯灣80%的出口產品。各國競相抬高現貨價格,並越來越多地尋求動用中國的戰略儲備以避免短缺。 「有報道稱,一些(亞洲)國家的農村地區持續出現燃料短缺,而燃料分配似乎有些混亂。我們看到越來越多的政府間協議,例如中國允許向友好國家出口部分燃料,泰國也在考慮向鄰國提供更多支持,」麥格理集團全球能源策略師維卡斯·德維迪寫道。 然而,目前幾乎沒有任何跡象表明雙方將就結束戰爭和重新開放被封鎖的海峽進行談判。原定於上週末在巴基斯坦舉行的美伊會談因美國拒絕伊朗解除對其港口封鎖的要求而未能舉行。 《華爾街日報》報道稱,美國總統川普正呼籲其他國家加入一個旨在重新開放霍爾木茲海峽的聯盟,美國政府稱之為「海上自由聯盟」。美國正尋求其駐外使館敦促盟友加入該聯盟。同時,川普警告稱,除非伊朗同意終止其核子計劃,否則霍爾木茲海峽的封鎖將持續下去。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of Firstenergy Corp.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target by $1 to $55, 20.0x our next-12-month EPS view of $2.75, a premium to its five-year average of 15.6x. We reduce our 2026 EPS view by $0.02 to $2.72 and 2027 EPS by $0.01 to $2.93. The Q1 core EPS increase (+7.5% Y/Y) breaks a three-quarter streak of declines, and we see continued momentum throughout our forecast horizon. We see positive data center demand trends, with long-term contracted demand (4.3 GW) up 4% since February 2026 (4.1 GW) and up 47% since February 2025 (2.9 GW), while pipeline demand (14.9 GW) is up 15% since February 2026 (12.9 GW) and has more than doubled since February 2025 (6.1 GW). FE has reduced base O&M by over $200M (15%) since 2022, with Q1 2026 showing an additional ~5% YoY decline, while simultaneously improving reliability metrics. We think FE's cost discipline, service quality improvement, and competitive rate positioning should translate into more favorable rate case outcomes, reduced disallowance risk, and potentially higher allowed ROEs.
Sector Update: Consumer
Consumer stocks were higher Thursday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) rising 1.4% and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) increasing 0.4%.In corporate news, Lamb Weston (LW) shares rose 1.6% after shareholder Starboard Value said in a letter to the board Thursday that the company should hold an investor day and reset earnings to a normalized level.
Market Chatter: FDA Panel Votes Against Benefits of AstraZeneca's Breast Cancer Drug
The US Food and Drug Administration's Oncology Drugs Advisory Committee rejected the benefits AstraZeneca's (AZN) Camizestrant drug candidate to treat breast cancer, Bloomberg reported Thursday.Six committee members voted against the drug due to disagreement over the trial design and the potential implications in the clinical setting, according to Bloomberg.The drug trial met is primary endpoint of progression-free survival as well as the progression-free survival 2 endpoint, however, FDA does not consider PFS2 a suitable endpoint for regulatory decision making, according to a briefing document.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $189.60, Change: $+4.40, Percent Change: +2.37%